Study Of Generalized Anxiety Disorder

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

May 31, 2006

Conditions
Anxiety DisorderAnxiety Disorders
Interventions
DRUG

Paroxetine

"Fixed Dose (20 mg/day): The fixed dose of 20 mg/day was selected, because it is the recommended dose for the treatment of GAD in the US and other countries.~Flexible Dose (20 - 40 mg/day): Overseas, the maximum dose in the treatment of GAD is 50 mg/day. However, 40 mg/day was selected as the maximum dose for this flexible dose session, because overseas clinical studies have indicated that paroxetine is sufficiently effective at doses of 20 - 40 mg/day and this is the dose range approved for depression/depressive episodes in Japan."

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY